Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-26

Clinical Trial Update: Rectal Indomethacin to Prevent Post ESWL-pancreatitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing rectal indomethacin to prevent post-ESWL pancreatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatitis | Phase 4 | Status: COMPLETED | Results posted: 2022-05-26